Clinical Trial

A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis

Name: A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis — clinical trial record (NCT07321951)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This trial was designed to evaluate the efficacy and safety of SHR-1819 in adult patients with moderate-to-severe atopic dermatitis.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-05

Trial Details

NCT Number	NCT07321951
Lead Sponsor	Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions	Moderate-to-severe Atopic Dermatitis
Enrollment	201 participants
Start Date	2026-01-09
Primary Completion	2027-06 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-06-04